Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP687585.RATiPE2-PsA2XnjTltsKawhmDhTQJgOtaL7SzgPKtRrZQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP687585.RATiPE2-PsA2XnjTltsKawhmDhTQJgOtaL7SzgPKtRrZQ130_assertion type Assertion NP687585.RATiPE2-PsA2XnjTltsKawhmDhTQJgOtaL7SzgPKtRrZQ130_head.
- NP687585.RATiPE2-PsA2XnjTltsKawhmDhTQJgOtaL7SzgPKtRrZQ130_assertion description "[Our data suggest that reduced expression of miR-200b and miR-15b underscores the mechanisms of chemotherapy-induced EMT in TSCC, and may serve as therapeutic targets to reverse chemotherapy resistance in tongue cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687585.RATiPE2-PsA2XnjTltsKawhmDhTQJgOtaL7SzgPKtRrZQ130_provenance.
- NP687585.RATiPE2-PsA2XnjTltsKawhmDhTQJgOtaL7SzgPKtRrZQ130_assertion evidence source_evidence_literature NP687585.RATiPE2-PsA2XnjTltsKawhmDhTQJgOtaL7SzgPKtRrZQ130_provenance.
- NP687585.RATiPE2-PsA2XnjTltsKawhmDhTQJgOtaL7SzgPKtRrZQ130_assertion SIO_000772 21725369 NP687585.RATiPE2-PsA2XnjTltsKawhmDhTQJgOtaL7SzgPKtRrZQ130_provenance.
- NP687585.RATiPE2-PsA2XnjTltsKawhmDhTQJgOtaL7SzgPKtRrZQ130_assertion wasDerivedFrom befree-20140225 NP687585.RATiPE2-PsA2XnjTltsKawhmDhTQJgOtaL7SzgPKtRrZQ130_provenance.
- NP687585.RATiPE2-PsA2XnjTltsKawhmDhTQJgOtaL7SzgPKtRrZQ130_assertion wasGeneratedBy ECO_0000203 NP687585.RATiPE2-PsA2XnjTltsKawhmDhTQJgOtaL7SzgPKtRrZQ130_provenance.